Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03246529
Title A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and G-GSF as Compared to Placebo and G-CSF for thE MobilizatioN of HematopoiEtic Stem Cells for Autologous TransplantatIon in SubjectS With MM (GENESIS)
Acronym GENESIS
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors BioLineRx, Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | HUN | ESP | DEU

Facility Status City State Zip Country Details
UCLA Medical Center Los Angeles California 167817 United States Details
University of Florida Gainesville Florida 100278 United States Details
University of Miami Miami Florida 33136 United States Details
Loyola University Medical Center Chicago Illinois 60611 United States Details
University of Maryland Baltimore Maryland 21201 United States Details
Mayo Clinic Rochester Minnesota 55902 United States Details
The Washington University School of Medicine Saint Louis Missouri 63110 United States Details
University of Cincinnati Cincinnati Ohio 45221 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Huntsman Cancer Institute in University of Utah Salt Lake City Utah 84112 United States Details
University of Koln Köln Koln 50923 Germany Details
Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases Budapest 1097 Hungary Details
University of Debrecen Debrecen 4032 Hungary Details
Div. Clinicizzata di Ematologia - Policlinico Vittorio Emanuele Catania 95124 Italy Details
Presidio Ospedaliero Morelli Viale Europa Reggio Calabria 89133 Italy Details
Hospital de La Santa Creu I Sant Pau Barcelona 08041 Spain Details
Hospital University Ramon y Cajal Madrid 135250 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field